Technologies announces its role in supporting Autolus Therapeutics’ FDA approval for AUCATZYL, a recently approved CAR T therapy.

Bank of America Securities analyst Michael Ryskin maintained a Hold rating on Agilent (A – Research Report) today and set a price target of ...